Radix Polygalae Extract-Based Therapies for Novel Health Applications

Publication ID: 24-11857592_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Radix Polygalae Extract-Based Therapies for Novel Health Applications,” Published Technical Disclosure No. 24-11857592_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857592_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,592.

Summary of the Inventive Concept

This inventive concept leverages the core technology of Radix Polygalae extract to treat a range of novel health applications beyond attention-deficit hyperactivity disorder (ADHD), including chronic pain, fibromyalgia, irritable bowel syndrome, Alzheimer's disease, and post-traumatic stress disorder.

Background and Problem Solved

The original patent disclosed a method for treating ADHD using Radix Polygalae extract. However, the limitations of the original patent lie in its narrow focus on ADHD treatment. The present inventive concept addresses this limitation by exploring the application of Radix Polygalae extract in entirely new industries and fields, unlocking its potential to improve human health and quality of life.

Detailed Description of the Inventive Concept

The inventive concept involves administering Radix Polygalae extract-based compositions to subjects in need thereof for treating various health conditions. The extract's active compounds interact with the body's biochemical pathways to modulate pain perception, reduce inflammation, and improve cognitive function. Specifically, the new claims encompass systems and methods for improving sleep quality in patients with chronic pain, treating fibromyalgia, reducing anxiety in patients with irritable bowel syndrome, improving cognitive function in patients with Alzheimer's disease, and reducing symptoms of post-traumatic stress disorder.

Novelty and Inventive Step

The novelty of the present inventive concept lies in the unexpected application of Radix Polygalae extract to treat novel health applications beyond ADHD. The inventive step involves recognizing the extract's potential to address a broader range of health conditions, and developing compositions and methods tailored to these specific applications.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may involve varying the formulation, dosage, and route of administration of the Radix Polygalae extract-based compositions. Additionally, the extract could be combined with other active compounds or excipients to enhance its therapeutic effects. Other variations may include developing topical or transdermal formulations for localized treatment of pain and inflammation.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, with potential applications in pain management, neurology, and psychiatry. The target market includes patients suffering from chronic pain, fibromyalgia, irritable bowel syndrome, Alzheimer's disease, and post-traumatic stress disorder, as well as healthcare providers seeking innovative therapeutic solutions.

CPC Classifications

SectionClassGroup
A A61 A61K36/69
A A61 A61K9/0053
A A61 A61K9/485
A A61 A61K9/4825
A A61 A61K9/4858
A A61 A61K47/02
A A61 A61K47/12
A A61 A61P25/28
A A61 A61K2236/333

Field of Art

Pharmaceutical compositions, botanical extracts, and neurological/psychiatric disorder treatments, with expertise in pharmacological formulation, botanical extraction techniques, and therapeutic applications of natural compounds

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced training in pharmacology, medicinal chemistry, or botanical medicine, possessing knowledge of herbal extract preparation, drug delivery systems, and therapeutic applications across neurological and pain management domains

Obviousness Rationale

A PHOSITA would recognize that the Radix Polygalae extract's demonstrated neurological and cognitive modulation effects in the ADHD treatment context provide a clear scientific foundation for exploring related therapeutic applications. The extract's demonstrated ability to interact with neurological pathways suggests predictable extensions to other neurological and pain-related conditions. The systematic exploration of alternative health applications represents a standard scientific approach to understanding a novel botanical compound's therapeutic potential.

Obvious Combinations & Variations

Source Patent Element
Radix Polygalae extract composition for treating ADHD symptoms
PTD Variation
Extending extract application to chronic pain and sleep quality management
Obviousness Reasoning
Known pharmacological principle of repurposing compounds with neurological activity for related therapeutic domains, with predictable potential for pain and sleep modulation
Source Patent Element
Oral administration method for neurological symptom management
PTD Variation
Applying similar oral administration techniques to fibromyalgia and PTSD treatment
Obviousness Reasoning
Established pharmaceutical practice of translating successful administration methods across related neurological conditions, representing a routine design optimization
Source Patent Element
Composition including silicon dioxide and magnesium stearate as excipients
PTD Variation
Exploring alternative excipient combinations for enhanced bioavailability and targeted delivery
Obviousness Reasoning
Standard pharmaceutical engineering approach of modifying excipient profiles to optimize drug performance across different therapeutic contexts
Source Patent Element
Treatment targeting cognitive and behavioral symptoms
PTD Variation
Expanding symptom management to Alzheimer's disease and cognitive processing
Obviousness Reasoning
Logical scientific progression of investigating compound's potential in neurologically related conditions with similar underlying mechanisms
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857592 regarding Radix Polygalae extract's neurological applications, a person of ordinary skill in the art would find the present published technical disclosure's expanded therapeutic variations obvious and predictable, thereby establishing prior art that would render subsequent similar claims non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,592
TitlePolygala extract for the treatment of attention-deficit hyperactivity disorder
Assignee(s)BioLite Inc.